addition of the  xxxg2193xxx  antagonist  xxxd203xxx  to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomi...   xxxd203xxx  is a novel  xxxg2240xxx  (nk(1)) antagonist that has been shown to improve control of chemotherapy-induced nausea and vomiting (cinv) when added to a standard antiemetic regimen of a 5-hydroxytriptamine-3 antagonist plus a corticosteroid. the authors sought to evaluate further the efficacy and tolerability of  xxxd203xxx  plus standard therapy in a large clinical trial.